Antitrust Laws, Drug Industry, Drugs, Europe, European Union, Generic, Guidelines as Topic, Health Services Accessibility, Humans, International Agencies, Marketing of Health Services, Patents as Topic, article, drug industry, economic aspect, priority journal
dx.doi.org/10.1016/S0140-6736(09)61370-2, hdl.handle.net/1765/16948
The Lancet
Erasmus School of Economics

den Exter, A.P. (2009). European Commission takes on Big Pharma. The Lancet, 374(9690), 599–600. doi:10.1016/S0140-6736(09)61370-2